Randomized adaptive assessment of post COVID syndrome treatments (RAPID): a study protocol for a multicenter, randomized, controlled adaptive platform trial of treatment options for Post Covid Syndrome (PCS) on patients physical function including the first intervention specific appendix RAPID_REVIVE (reducing inflammatory activity in patients with PCS).

Weipert L, Telgmann RG, Anton G, Asendorf T, Chaplinskaja-Sobol I, Ciesek S, Cornely OA, Drescher S, Finke C, Friede T, Groth J, Hanß S, Hoffmann W, Huber C, Illig T, Kraus M, Krefting D, Kuhn S, Muehler A, Nauck M, Schaller J, Schmidt AC, Schmidt G, Sawitzki B, Tostmann R, Valentin H, Vehreschild M

Trials

2025 Aug

26(1):297

10.1186/s13063-025-09008-0 [doi]. PMID: 40830806

Newest Publications

  • Mild hypothermia provides Treg stability

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies

  • Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral blood

  • Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization

  • CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures

  • TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity

  • BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study

  • Gravitational stress during parabolic flights reduces the number of circulating innate and adaptive leukocyte subsets in human blood

  • A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studies

  • The AICL-KLRF1 axis supports CD4-CD8 T cell communication and cytokine competence in pre-exhausted CD8+ T cells

Sawitzki Lab

Berlin Institute of Health at Charité (BIH) 
Center of Immunomics/Translational Immunology

Luisenstraße 65 
D-10117 Berlin